Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial.

Maizels M, Blumenfeld A, Burchette R.

Headache. 2004 Oct;44(9):885-90.

PMID:
15447697
2.

The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis--a double-blind, multicentre, randomized placebo-controlled dose-response study.

Pfaffenrath V, Diener HC, Fischer M, Friede M, Henneicke-von Zepelin HH; Investigators.

Cephalalgia. 2002 Sep;22(7):523-32.

PMID:
12230594
3.

A double-blind placebo-controlled pilot study of sublingual feverfew and ginger (LipiGesic™ M) in the treatment of migraine.

Cady RK, Goldstein J, Nett R, Mitchell R, Beach ME, Browning R.

Headache. 2011 Jul-Aug;51(7):1078-86. doi: 10.1111/j.1526-4610.2011.01910.x. Epub 2011 Jun 1.

PMID:
21631494
4.

Feverfew for migraine prophylaxis.

Henneicke-von Zepelin HH.

Headache. 2006 Mar;46(3):531. No abstract available.

PMID:
16618282
5.

Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, placebo-controlled, double-blind, multicenter trial.

Gaul C, Diener HC, Danesch U; Migravent® Study Group.

J Headache Pain. 2015;16:516. doi: 10.1186/s10194-015-0516-6. Epub 2015 Apr 3.

6.

High-dose riboflavin for migraine prophylaxis in children: a double-blind, randomized, placebo-controlled trial.

MacLennan SC, Wade FM, Forrest KM, Ratanayake PD, Fagan E, Antony J.

J Child Neurol. 2008 Nov;23(11):1300-4. doi: 10.1177/0883073808318053.

PMID:
18984840
7.

Feverfew for preventing migraine.

Pittler MH, Ernst E.

Cochrane Database Syst Rev. 2004;(1):CD002286. Review.

PMID:
14973986
8.

Evidenced-based use of botanicals, minerals, and vitamins in the prophylactic treatment of migraines.

Rios J, Passe MM.

J Am Acad Nurse Pract. 2004 Jun;16(6):251-6. Review.

PMID:
15264611
9.

Feverfew for preventing migraine.

Pittler MH, Vogler BK, Ernst E.

Cochrane Database Syst Rev. 2000;(3):CD002286. Review. Update in: Cochrane Database Syst Rev. 2004;(1):CD002286.

PMID:
10908545
10.

Randomised double-blind placebo-controlled trial of feverfew in migraine prevention.

Murphy JJ, Heptinstall S, Mitchell JR.

Lancet. 1988 Jul 23;2(8604):189-92.

PMID:
2899663
11.

The efficacy and safety of feverfew (Tanacetum parthenium L.): an update of a systematic review.

Ernst E, Pittler MH.

Public Health Nutr. 2000 Dec;3(4A):509-14. Review.

PMID:
11276299
12.

Tanacetum parthenium and Salix alba (Mig-RL) combination in migraine prophylaxis: a prospective, open-label study.

Shrivastava R, Pechadre JC, John GW.

Clin Drug Investig. 2006;26(5):287-96.

PMID:
17163262
13.

Efficacy of feverfew as prophylactic treatment of migraine.

Johnson ES, Kadam NP, Hylands DM, Hylands PJ.

Br Med J (Clin Res Ed). 1985 Aug 31;291(6495):569-73.

14.

Non-pharmacological approach to migraine prophylaxis: part II.

Schiapparelli P, Allais G, Castagnoli Gabellari I, Rolando S, Terzi MG, Benedetto C.

Neurol Sci. 2010 Jun;31 Suppl 1:S137-9. doi: 10.1007/s10072-010-0307-4. Review.

PMID:
20464605
15.

Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention--a randomized, double-blind, multicentre, placebo-controlled study.

Diener HC, Pfaffenrath V, Schnitker J, Friede M, Henneicke-von Zepelin HH.

Cephalalgia. 2005 Nov;25(11):1031-41.

PMID:
16232154
16.

New medications show promise for migraine sufferers.

[No authors listed]

Dent Today. 2002 Oct;21(10):70. No abstract available.

PMID:
12382492
17.

Efficacy of botulinum toxin type A for the prophylaxis of episodic migraine headaches: a meta-analysis of randomized, double-blind, placebo-controlled trials.

Shuhendler AJ, Lee S, Siu M, Ondovcik S, Lam K, Alabdullatif A, Zhang X, Machado M, Einarson TR.

Pharmacotherapy. 2009 Jul;29(7):784-91. doi: 10.1592/phco.29.7.784.

PMID:
19558252
18.

Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial.

Schoenen J, Jacquy J, Lenaerts M.

Neurology. 1998 Feb;50(2):466-70.

PMID:
9484373
19.

Feverfew for preventing migraine.

Wider B, Pittler MH, Ernst E.

Cochrane Database Syst Rev. 2015 Apr 20;4:CD002286. [Epub ahead of print]

PMID:
25892430
20.

Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trial.

Diener HC, Agosti R, Allais G, Bergmans P, Bussone G, Davies B, Ertas M, Lanteri-Minet M, Reuter U, Sánchez Del Río M, Schoenen J, Schwalen S, van Oene J; TOPMAT-MIG-303 Investigators Group.

Lancet Neurol. 2007 Dec;6(12):1054-62. Epub 2007 Nov 7. Erratum in: Lancet Neurol. 2008 Jan;7(1):25.

PMID:
17988947

Supplemental Content

Support Center